LAFYX
Price
$18.74
Change
-$0.53 (-2.75%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

LAFYX vs RMFCX

Header iconLAFYX vs RMFCX Comparison
Open Charts LAFYX vs RMFCXBanner chart's image
Lord Abbett Affiliated I
Price$18.74
Change-$0.53 (-2.75%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
LAFYX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LAFYX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAFYX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. LAFYX (6.2B). LAFYX (1.70) and RMFCX (1.69) have matching dividends . LAFYX was incepted earlier than RMFCX: LAFYX (27 years) vs RMFCX (23 years). LAFYX is a more actively managed with annual turnover of: 57.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than LAFYX: RMFCX (250) vs LAFYX (1000000). LAFYX annual gain was more profitable for investors over the last year : 16.55 vs. RMFCX (12.63). RMFCX return over 5 years is better than : 40.39 vs. LAFYX (28.60).
LAFYXRMFCXLAFYX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years23 years-
Gain YTD15.13811.423133%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.2B98.7B6%
Annual Yield % from dividends1.701.69101%
Returns for 1 year16.5512.63131%
Returns for 3 years10.4714.1674%
Returns for 5 years28.6040.3971%
Returns for 10 years33.8961.8455%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc